Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.
It is estimated that as many as 1.4 million Canadian women may be afflicted with polycystic ovary syndrome (PCOS). Although PCOS is heralded as one of the most common endocrine disorders occurring in women, its diagnosis, management, and associated long-term health risks remain controversial. Historically, the combination of androgen excess and anovulation has been considered the hallmark of PCOS. To date, while these symptoms remain the most prevalent among PCOS patients, neither is considered an absolute requisite for the syndrome. Inclusion of ultrasonographic evidence of polycystic ovaries as a diagnostic marker has substantially broadened the phenotypic spectrum of PCOS, yet much debate surrounds the validity of these newly identified milder variants of the syndrome. Difficulty in resolving the spectrum of PCOS stems from the continued use of inconsistent and inaccurate methods of evaluating androgen excess, anovulation, and polycystic ovaries on ultrasound. At present, there is no clear-cut definition of biochemical hyperandrogenemia, particularly since we depend on poor laboratory standards for measuring androgens in women. Clinical signs of hyperandrogenism are ill-defined in women with PCOS, and the diagnosis of both hirsutism and polycystic ovarian morphology remains alarmingly subjective. Lastly, there is an inappropriate tendency to assign ovulatory status solely on the basis of menstrual cycle history or poorly timed endocrine measurements. In this review, we elaborate on these limitations and propose possible resolutions for clinical and research settings. By stimulating awareness of these limitations, we hope to generate a dialogue aimed at solidifying the evaluation of PCOS in Canadian women.
Lujan
Marla E
ME
Department of Obstetrics, Gynecology and Reproductive Sciences, College of Medicine, University of Saskatchewan, Saskatoon SK.
Chizen
Donna R
DR
Department of Obstetrics, Gynecology and Reproductive Sciences, College of Medicine, University of Saskatchewan, Saskatoon SK.
Pierson
Roger A
RA
Department of Obstetrics, Gynecology and Reproductive Sciences, College of Medicine, University of Saskatchewan, Saskatoon SK.
D000152:Acne Vulgaris / Q000209:etiology; D000505:Alopecia / Q000209:etiology; D000728:Androgens / Q000097:blood; D000858:Anovulation / Q000175:diagnosis / Q000209:etiology; D015415:Biomarkers / Q000097:blood; D005260:Female; D006628:Hirsutism / Q000209:etiology; D006801:Humans; D017588:Hyperandrogenism / Q000209:etiology; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis*; D012015:Reference Standards
D000728:Androgens; D015415:Biomarkers
Hum Reprod. 2003 Mar;18(3):598-603
12615832
Ultrasound Obstet Gynecol. 1995 Sep;6(3):182-5
8521067
Fertil Steril. 2004 Jan;81(1):19-25
14711538
Fertil Steril. 2005 Aug;84(2):413-9
16084883
Reprod Biol Endocrinol. 2008 Jul 18;6:30
18638401
J Clin Endocrinol Metab. 2006 Nov;91(11):4237-45
16940456
Clin Endocrinol (Oxf). 2007 Apr;66(4):513-7
17371468
J Clin Endocrinol Metab. 1999 Nov;84(11):4006-11
10566641
Clin Endocrinol (Oxf). 2007 Dec;67(6):811-5
17760885
J Clin Endocrinol Metab. 2006 Oct;91(10):3922-7
16849400
Fertil Steril. 2007 Jun;87(6):1369-76
17397839
Aust N Z J Obstet Gynaecol. 1994 Feb;34(1):67-72
8053879
Lancet. 2007 Aug 25;370(9588):685-97
17720020
J Clin Endocrinol Metab. 2005 Jul;90(7):4112-4
15827102
Hum Reprod. 2006 Dec;21(12):3108-15
17053004
J Am Acad Dermatol. 2007 Apr;56(4):651-63
17276540
Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):864
6423124
J Hepatol. 2007 Sep;47(3):412-7
17560682
Eur J Endocrinol. 2001 Nov;145(5):619-24
11720881
Eur J Endocrinol. 2003 Nov;149(5):439-42
14585091
Gynakol Geburtshilfliche Rundsch. 1993;33(3):173-9
8298311
J Clin Endocrinol Metab. 2006 Jan;91(1):36-42
16219719
J Clin Endocrinol Metab. 1961 Nov;21:1440-7
13892577
Br J Dermatol. 1977 Sep;97(3):247-54
921894
Hum Reprod. 2002 Sep;17(9):2219-27
12202405
Fertil Steril. 2005 May;83(5):1343-6
15866567
Fertil Steril. 2006 Nov;86(5 Suppl 1):S264-7
17055838
Hum Reprod Update. 2003 Nov-Dec;9(6):505-14
14714587
Lancet. 1997 Oct 18;350(9085):1131-5
9343501
J Clin Endocrinol Metab. 1998 Sep;83(9):3078-82
9745406
Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):235-44
16772154
Acta Obstet Gynecol Scand. 2003 Jan;82(1):61-4
12580842
N Engl J Med. 2005 Dec 15;353(24):2578-88
16354894
Hum Reprod. 1995 Sep;10(9):2258-61
8530647
J Am Acad Dermatol. 1999 Oct;41(4):577-80
10495379
Clin Endocrinol (Oxf). 2001 Oct;55(4):439-46
11678825
Fertil Steril. 2005 Jun;83(6):1717-23
15950641
Best Pract Res Clin Obstet Gynaecol. 2004 Oct;18(5):813-23
15380149
Biol Reprod. 2003 Sep;69(3):1023-31
12748128
J Clin Endocrinol Metab. 2006 Apr;91(4):1345-50
16449347
J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9
15181052
Hum Reprod. 2002 Jun;17(6):1616-22
12042287
J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8
10902790
Fertil Steril. 2006 Jan;85(1):214-9
16412756
J Clin Endocrinol Metab. 2001 Jun;86(6):2903
11397908
Annu Rev Med. 2001;52:401-19
11160786
Ultrasound Obstet Gynecol. 2005 May;25(5):498-507
15846762
CMAJ. 2003 Aug 5;169(3):207-8
12900479
J Clin Endocrinol Metab. 2006 Dec;91(12):4842-8
17003085
Skinmed. 2003 Jul-Aug;2(4):222-8
14673275
BJOG. 2006 Oct;113(10):1210-7
16972863
Clin Endocrinol (Oxf). 2007 Dec;67(6):809-10
17727675
Clin Endocrinol (Oxf). 2007 Nov;67(5):735-42
17760884
Fertil Steril. 1999 Feb;71(2):319-22
9988405
J Clin Endocrinol Metab. 2007 Feb;92(2):405-13
17090633
Am J Med. 2001 Dec 1;111(8):602-6
11755502
Fertil Steril. 2001 Aug;76(2):326-31
11476780
Aust N Z J Obstet Gynaecol. 2001 May;41(2):202-6
11453273
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
10523012
Postgrad Med J. 1983 Jan;59(687):17-20
6866869